FDA, Cardinal Strike Deal On Defective Drug Pumps
The health care products maker signed a consent decree with the FDA on Thursday. Cardinal will be required to make a number of changes to the design, manufacture, packaging, labeling and distribution of its Alaris SE infusion pump, formerly known as Signature Edition Infusion System.
The FDA classified the case a Class I recall, which...
To view the full article, register now.